HU0002691A3 - Medicinal aerosol products containing ciclesonide - Google Patents

Medicinal aerosol products containing ciclesonide

Info

Publication number
HU0002691A3
HU0002691A3 HU0002691A HU0002691A HU0002691A3 HU 0002691 A3 HU0002691 A3 HU 0002691A3 HU 0002691 A HU0002691 A HU 0002691A HU 0002691 A HU0002691 A HU 0002691A HU 0002691 A3 HU0002691 A3 HU 0002691A3
Authority
HU
Hungary
Prior art keywords
products containing
aerosol products
medicinal aerosol
containing ciclesonide
ciclesonide
Prior art date
Application number
HU0002691A
Other versions
HU226694B1 (en
HU0002691A2 (en
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GBGB9710496.2A priority Critical patent/GB9710496D0/en
Priority to GBGB9803990.2A priority patent/GB9803990D0/en
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Priority to PCT/US1998/010155 priority patent/WO1998052542A1/en
Publication of HU0002691A2 publication Critical patent/HU0002691A2/en
Publication of HU0002691A3 publication Critical patent/HU0002691A3/en
Publication of HU226694B1 publication Critical patent/HU226694B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • A61K9/124Aerosols; Foams characterised by the propellant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or anti-inflammatory agents, e.g antirheumatic agents; Non-steroidal anti-inflammatory drugs (NSAIDs)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00Drug, bio-affecting and body treating compositions
    • Y10S514/826Asthma
HU0002691A 1997-05-21 1998-05-18 Medicinal aerosol products containing ciclesonide HU226694B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9710496.2A GB9710496D0 (en) 1997-05-21 1997-05-21 Medicinal aerosol products
GBGB9803990.2A GB9803990D0 (en) 1998-02-25 1998-02-25 Medicinal aerosol products
PCT/US1998/010155 WO1998052542A1 (en) 1997-05-21 1998-05-18 Medicinal aerosol products

Publications (3)

Publication Number Publication Date
HU0002691A2 HU0002691A2 (en) 2001-02-28
HU0002691A3 true HU0002691A3 (en) 2001-04-28
HU226694B1 HU226694B1 (en) 2009-06-29

Family

ID=26311564

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002691A HU226694B1 (en) 1997-05-21 1998-05-18 Medicinal aerosol products containing ciclesonide

Country Status (28)

Country Link
US (1) US6120752A (en)
EP (1) EP0983058B1 (en)
JP (4) JP2001526685A (en)
KR (1) KR100527643B1 (en)
CN (1) CN1149073C (en)
AT (1) AT245966T (en)
AU (1) AU726835B2 (en)
BG (1) BG64268B1 (en)
BR (1) BR9809448A (en)
CA (1) CA2290521C (en)
CZ (1) CZ298253B6 (en)
DE (1) DE69816811T2 (en)
DK (1) DK0983058T3 (en)
EA (1) EA002381B1 (en)
ES (1) ES2205491T3 (en)
HK (1) HK1027027A1 (en)
HU (1) HU226694B1 (en)
IL (1) IL132738A (en)
ME (1) ME01631B (en)
NO (2) NO327716B1 (en)
NZ (1) NZ500874A (en)
PL (1) PL191523B1 (en)
PT (1) PT983058E (en)
RS (1) RS49628B (en)
SK (1) SK283930B6 (en)
TR (1) TR199902863T2 (en)
UA (1) UA58551C2 (en)
WO (1) WO1998052542A1 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US6315985B1 (en) 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
AR026073A1 (en) * 1999-10-20 2002-12-26 Nycomed Gmbh aqueous pharmaceutical composition containing ciclesonide that
AR026072A1 (en) * 1999-10-20 2002-12-26 Nycomed Gmbh pharmaceutical composition containing ciclesonide for application to the mucosa
GB0002798D0 (en) * 2000-02-09 2000-03-29 Glaxo Group Ltd Actuator nozzle for metered dose inhaler
GB0207899D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and cielesonide aerosol formulations
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
AU2003291634A1 (en) * 2002-10-08 2004-05-04 Sepracor Inc. Fatty acid modified forms of glucocorticoids and their use as anti-inflammatory
DK2036943T4 (en) * 2002-10-25 2017-04-03 Honeywell Int Inc Use of a composition comprising 1,3,3,3-tetrafluoropropene (HFO 1234ze) as blowing agent
US9308199B2 (en) 2004-04-29 2016-04-12 Honeywell International Inc. Medicament formulations
DK1572217T3 (en) * 2002-12-12 2008-12-15 Nycomed Gmbh Combination drug of R, R-formoterol and ciclesonide
MY143936A (en) * 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
JP2006528228A (en) * 2003-05-22 2006-12-14 アルタナ ファルマ アクチエンゲゼルシャフトALTANA Pharma AG Salmeterol and ciclesonide combination
JP2006527237A (en) * 2003-06-13 2006-11-30 アルタナ ファルマ アクチエンゲゼルシャフトALTANA Pharma AG Combination of formoterol and ciclesonide
PT1670482E (en) * 2003-09-16 2014-03-12 Takeda Gmbh Use of ciclesonide for the treatment of respiratory diseases
GB2406283B (en) 2003-09-24 2006-04-05 Altana Pharma Ag Compliance monitor and method
AR041873A1 (en) * 2003-10-30 2005-06-01 Pablo Cassara Srl Lab A pharmaceutical aerosol formulation suitable for oral or nasal inhalation containing glucocorticoid in solution to stable storage; a method for estabilzar formulations and use of a stabilizing agent
PE20050941A1 (en) * 2003-12-16 2005-11-08 Nycomed Gmbh Aqueous suspensions of ciclesonide for aerosolisation
US20050153946A1 (en) * 2003-12-24 2005-07-14 Collegium Pharmaceuticals, Inc. Temperature-stable formulations, and methods of development thereof
AU2005235384B2 (en) * 2004-04-20 2010-09-09 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
CA2579007A1 (en) * 2004-09-10 2006-03-16 Altana Pharma Ag Ciclesonide and syk inhibitor combination and methods of use thereof
WO2006101882A2 (en) * 2005-03-16 2006-09-28 Honeywell International Inc. Medicament delivery formulations, devices and methods
WO2007068007A1 (en) * 2005-12-07 2007-06-14 Harm Benjamin Steyn Use of a disinfectant for treating respiratory tract infections
US8148377B2 (en) 2007-02-11 2012-04-03 Map Pharmaceuticals, Inc. Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
US20100120737A1 (en) * 2008-11-10 2010-05-13 Martin Feth Amorphous ciclesonide
CN102348714B (en) * 2009-03-09 2015-01-07 三笠制药株式会社 Steroid compound
WO2011135585A2 (en) 2010-04-28 2011-11-03 Cadila Healthcare Limited Aqueous pharmaceutical solution of ciclesonide
MX2013004137A (en) * 2010-10-12 2013-07-29 Cipla Ltd Pharmaceutical composition.
MX2014001940A (en) 2011-08-18 2014-03-27 Takeda Gmbh Pharmaceutical aerosol product for administration by oral or nasal inhalation.
CN102335132A (en) * 2011-10-12 2012-02-01 中山大学 Asarin inhalation aerosol and preparation method thereof
US9603906B2 (en) 2012-02-01 2017-03-28 Protalix Ltd. Inhalable liquid formulations of DNase I
US20170304459A1 (en) 2014-10-10 2017-10-26 Alnylam Pharmaceuticals, Inc. Methods and compositions for inhalation delivery of conjugated oligonucleotide

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2077229B (en) * 1980-05-16 1983-08-03 Neotechnic Eng Ltd Valve assembly for a pressurized aerosoldispensing container
GB8824804D0 (en) * 1988-10-22 1988-11-30 Fisons Plc Device
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
GB8900267D0 (en) * 1989-01-06 1989-03-08 Riker Laboratories Inc Narcotic analgesic formulations and apparatus containing same
GB8921222D0 (en) * 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Aerosol propellant compositions
DE4003272A1 (en) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg New gas mixtures and their use in medicine preparations
WO1991014422A1 (en) * 1990-03-23 1991-10-03 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
GR1001529B (en) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Process for the obtainment of a new pregna-1,4-diene-3,20-dione -16-17-acetal-21 esters
ES2064160T3 (en) * 1990-10-18 1995-01-16 Minnesota Mining & Mfg Aerosol formulation comprising 17.21-beclometasone dipropionate.
US5683676A (en) * 1991-12-12 1997-11-04 Glaxo Group Limited Canister containing aerosol formulations containing P134a and particulate medicaments
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
US5474758A (en) * 1993-07-28 1995-12-12 Minnesota Mining And Manufacturing Company Seals for use in an aerosol delivery device
DK0735884T3 (en) * 1993-12-20 2000-10-09 Minnesota Mining & Mfg Flunisolide aerosol formulations
DE19541689A1 (en) * 1994-11-14 1996-05-15 Byk Gulden Lomberg Chem Fab Medicament contg. ciclesonid and beta2-sympathomimetic
US5653961A (en) * 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
SK139197A3 (en) * 1995-04-14 1998-04-08 Glaxo Wellcome Inc Metered dose inhaler for beclomethasone dipropionate
CN1217654C (en) * 1995-04-14 2005-09-07 史密丝克莱恩比彻姆公司 Metered dose inhaler for albuterol
CZ296209B6 (en) * 1995-04-14 2006-02-15 Glaxo Wellcome Inc. Inhaler and inhalation system

Also Published As

Publication number Publication date
PL336885A1 (en) 2000-07-17
CA2290521C (en) 2006-10-10
AU726835B2 (en) 2000-11-23
JP2011102301A (en) 2011-05-26
CZ298253B6 (en) 2007-08-08
PL191523B1 (en) 2006-06-30
YU59899A (en) 2002-06-19
CZ412499A3 (en) 2000-02-16
EP0983058A1 (en) 2000-03-08
CN1149073C (en) 2004-05-12
NO995667D0 (en) 1999-11-18
CN1257421A (en) 2000-06-21
JP6087882B2 (en) 2017-03-01
JP6178459B2 (en) 2017-08-09
EP0983058B1 (en) 2003-07-30
HK1027027A1 (en) 2004-07-16
BG103902A (en) 2000-05-31
AT245966T (en) 2003-08-15
JP2015024999A (en) 2015-02-05
AU7496298A (en) 1998-12-11
SK157699A3 (en) 2000-05-16
ES2205491T3 (en) 2004-05-01
NO2009024I1 (en) 2009-11-02
HU0002691A2 (en) 2001-02-28
DK983058T3 (en)
KR100527643B1 (en) 2005-11-15
KR20010012810A (en) 2001-02-26
JP2016169222A (en) 2016-09-23
EA199900991A1 (en) 2000-08-28
CA2290521A1 (en) 1998-11-26
IL132738A (en) 2004-06-20
TR199902863T2 (en) 2000-05-22
PT983058E (en) 2003-12-31
NZ500874A (en) 2001-09-28
DE69816811T2 (en) 2004-04-15
NO995667L (en) 1999-11-18
RS49628B (en) 2007-08-03
ME01631B (en) 2007-08-03
NO327716B1 (en) 2009-09-14
WO1998052542A1 (en) 1998-11-26
IL132738D0 (en) 2001-03-19
EA002381B1 (en) 2002-04-25
NO2009024I2 (en) 2010-08-16
BR9809448A (en) 2000-06-20
HU226694B1 (en) 2009-06-29
UA58551C2 (en) 2003-08-15
US6120752A (en) 2000-09-19
DK0983058T3 (en) 2003-11-24
DE69816811D1 (en) 2003-09-04
BG64268B1 (en) 2004-08-31
JP2001526685A (en) 2001-12-18
SK283930B6 (en) 2004-05-04

Similar Documents

Publication Publication Date Title
DE69530325D1 (en) Aerosol drug formulations
EG23826A (en) Pharmaceutical formulations
GB2298789B (en) Pharmaceutical compositions
DE69519300T2 (en) Stable medicinal product containing oxaliplatine
HU9800792A3 (en) Benzylpiperidines and piperazines, their use and pharmaceutical compositions containing the same
GR3030529T3 (en) Stabilized medicinal aerosol solution formulations.
GB9424562D0 (en) Product
PL335764A1 (en) Cosmetic product
IL135536D0 (en) Ortho-anthranilamide derivatives and pharmaceutical compositions containing the same
ZA9409378B (en) A medicinal aerosol formulation
HU9600612D0 (en) Improved pharmaceutical formulation
GB9412301D0 (en) Hollow-needle drugs etc applicators
PL335388A1 (en) Aerosol dispenser
GB9523752D0 (en) Pharmaceutical formulations
IL115039A (en) Spiroazabicyclic compounds, their preparation and pharmaceutical compositions containing them
GB9606805D0 (en) Medicaments
IL114622D0 (en) Heteroaryl-oxazolidinones and pharmaceutical compositions containing them
DE69630460D1 (en) Medicinal products containing flurbi
GB9417524D0 (en) Pharmaceutical compositions
NZ281112A (en) Powdered insulin delivered as an aerosol
IL114447D0 (en) Multiple unit pharmaceutical preparation
CY2211B1 (en) Pharmaceutical compositions
ZA9502169B (en) Pharmaceutical compositions
HRP960034B1 (en) Novel pharmaceutical combination
GR3024161T3 (en) Pharmaceutical packaging.

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: 3M INNOVATIVE PROPERTIES COMPANY, US

Free format text: FORMER OWNER(S): MINNESOTA MINING AND MANUFACTURING CO., US; ALTANA PHARMA AG, DE; 3M COMPANY, US; 3M INNOVATIVE PROPERTIES COMPANY, US

Owner name: NYCOMED GMBH, DE

Free format text: FORMER OWNER(S): MINNESOTA MINING AND MANUFACTURING CO., US; ALTANA PHARMA AG, DE; 3M COMPANY, US; 3M INNOVATIVE PROPERTIES COMPANY, US

AA1S Information on application for a supplementary protection certificate

Free format text: PRODUCT NAME: CICLESONIDE; REG. NO/DATE: OGYI-T-9971/01-OGYI-T-9973/01 20041221; FIRST REG.: GB PL20141/0004-0006 20040416

Spc suppl protection certif: S0900014

Filing date: 20090818

Expiry date: 20180518

FG4S Grant of supplementary protection certificate

Free format text: PRODUCT NAME: CICLESONIDE; REG. NO/DATE: OGYI-T-9971/01-OGYI-T-9973/01 20041221; FIRST REG.: GB PL20141/0004-0006 20040416

Spc suppl protection certif: S0900014

Filing date: 20090818

Expiry date: 20180518

Extension date: 20190417

HC9A Change of name, address

Owner name: 3M INNOVATIVE PROPERTIES COMPANY, US

Free format text: FORMER OWNER(S): MINNESOTA MINING AND MANUFACTURING CO., US; 3M COMPANY, US; 3M INNOVATIVE PROPERTIES COMPANY, US; ALTANA PHARMA AG, DE; NYCOMED GMBH, DE

Owner name: TAKEDA GMBH, DE

Free format text: FORMER OWNER(S): MINNESOTA MINING AND MANUFACTURING CO., US; 3M COMPANY, US; 3M INNOVATIVE PROPERTIES COMPANY, US; ALTANA PHARMA AG, DE; NYCOMED GMBH, DE

GB9A Succession in title

Owner name: 3M INNOVATIVE PROPERTIES COMPANY, US

Free format text: FORMER OWNER(S): MINNESOTA MINING AND MANUFACTURING CO., US; TAKEDA GMBH, DE; 3M COMPANY, US; 3M INNOVATIVE PROPERTIES COMPANY, US; ALTANA PHARMA AG, DE; NYCOMED GMBH, DE

Owner name: TAKEDA GMBH, DE

Free format text: FORMER OWNER(S): MINNESOTA MINING AND MANUFACTURING CO., US; TAKEDA GMBH, DE; 3M COMPANY, US; 3M INNOVATIVE PROPERTIES COMPANY, US; ALTANA PHARMA AG, DE; NYCOMED GMBH, DE